The secret of successful digital health partnerships
Digital health is guaranteed to play a huge part in the future of pharma. Innovative technology that can improve patient access, increase quality of care, boost efficiency and personalise medicine already exists today and is evolving at breakneck speed. It's no surprise that players from both the pharmaceutical and tech sectors are looking for ways to make swift progress in this exciting new market. For the majority, partnership is the most effective route to success.
Partnering in Digital Health: Pharma and Tech Companies looks at progress to date, the key issues, pitfalls, challenges and opportunities. Based on detailed interviews with experts, this is an up-to-the-minute and comprehensive assessment of the current state of play, along with practical guidance on how to move forward.
Use this report to:
What to expect from this report
Selecting the right digital health partner is imperative if long term success is to be achieved—however it is clear to all that pharma and tech companies have significantly different ways of working. Knowledge is key, so the insights and opinions shared in Partnering in Digital Health: Pharma and Tech Companies will deepen understanding of the issues and lay out a roadmap of how best to work together to achieve the best results for all parties.
How did we do it?
Example insight included in Partnering in Digital Health: Pharma and Tech Companies
'When working with tech companies, pharma must keep simplicity in mind. Pharma may need to avoid over-engineered compliance processes by changing standard review and approval processes in light of the urgent necessity to meet the needs of a dynamic and technologically-driven market. However, it is still a priority to comply with regulatory expectations. In addition, the technology at the heart of the partnership must not be overly complicated or sophisticated. Pharma companies must be careful not to be dazzled by the promise of huge opportunities in digital health. At the very least, the technology must work in the market, and there must be evidence of this."
Example quote included in Partnering in Digital Health: Pharma and Tech Companies
"Notable [partnerships] could be two things; they could be those that worked well and those that failed miserably. For example, I have seen many companies failing to do their homework before going into partnering mode. Partnering for the purpose of partnering is not the right thing to do." Anders Dyhr Toft, MD, PhD, eMBA, Corporate VP of Commercial Innovation, Novo Nordisk
The expert panel for Partnering in Digital Health: Pharma and Tech Companies
Why buy now?
Compared to the fast-paced, agile and consumer-focused technology sector, pharmaceutical companies can seem slow and overly complex. But for patients, payers and solution providers to all get what they need from the impending boom in digital health, these two very different animals need to find ways to work together productively. This report goes one step closer towards reducing frustration and building understanding so that mutual benefits can be achieved. Neither can make significant strides alone; crafting strong working partnerships is the only way forward.
Why FirstWord reports are different
All Contents Copyright © 2021 Doctor's Guide Publishing Limited All Rights Reserved